August 1, 2016
(Managed Care Magazine) – Biopharmaceutical drugs, which are used in a wide range of therapies including vaccines and treatments for diabetes and cancer, are typically produced in large, centralized fermentation plants. This means they must be transported to the treatment site, which can be expensive, time-consuming, and challenging to execute in areas with poor supply chains. Now a portable production system, designed to manufacture a range of biopharmaceuticals on demand, has been developed by researchers at the Massachusetts Institute of Technology (MIT), with funding from the Defense Advanced Research Projects Agency.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.